Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
Chemotherapy-induced neuropathic pain is a common side effect for cancer patients which has limited effective treatment options. Kappa opioid receptor (KOR) agonists are a promising alternative to currently available opioid drugs due to their low abuse potential. In the current study, we have invest...
Saved in:
Main Authors: | Kelly F. Paton (Author), Dan Luo (Author), Anne C. La Flamme (Author), Thomas E. Prisinzano (Author), Bronwyn M. Kivell (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Potential of Kappa Opioid Agonists
by: Tyler C. Beck, et al.
Published: (2019) -
The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
by: Martin L. Dalefield, et al.
Published: (2022) -
The κ-Opioid Receptor Agonist U50488H Ameliorates Neuropathic Pain Through the Ca2+/CaMKII/CREB Pathway in Rats
by: Zhang XM, et al.
Published: (2022) -
Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review
by: Adrian Joseph Michel Bailey, et al.
Published: (2022) -
Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5'-guanidinonaltrindole and the biased kappa opioid receptor agonist 6'-guanidinonaltrindole in mice
by: Alan Cowan, et al.
Published: (2021)